SEP
RGEN icon

Signature Equity Partners’s Repligen RGEN Stock Holding History

Signature Equity Partners’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$819 Sell
6
-7
-54% -$860 ﹤0.01% 1351
2026
Q1 		$1.53K Hold
13
– – ﹤0.01% 1174
2025
Q4 		$2.13K Buy
+13
New +$2.04K ﹤0.01% 1194

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Signature Equity Partners's RGEN Position: Q2 2026 in Review

Signature Equity Partners reduced its Repligen (RGEN) stake by 54% in Q2 2026, selling an estimated $860 and leaving 6 shares worth $819. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Signature Equity Partners first reported a position in RGEN in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.13K in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Signature Equity Partners held 6 shares of Repligen worth $819 as of Q2 2026.
  • Signature Equity Partners sold 7 Repligen shares in Q2 2026, an estimated $860.
  • Repligen made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1351 holding.
  • Signature Equity Partners first reported a position in Repligen in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Repligen position peaked at $2.13K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.